Actively Recruiting
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
Led by First Affiliated Hospital, Sun Yat-Sen University · Updated on 2021-09-30
447
Participants Needed
1
Research Sites
309 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial is a multi-center phase III clinical trial. The purpose of this trial is to explore whether concurrent chemoradiotherapy is not inferior to induction chemotherapy combined with concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
CONDITIONS
Official Title
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 65 years old
- Pathologically confirmed non-keratinizing nasopharyngeal carcinoma
- Stage T3-4N0-1 disease according to UICC/AJCC 8th edition
- No distant metastasis
- No prior anti-cancer treatment
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Adequate blood, liver, and kidney function
You will not qualify if you...
- Treatment intended for palliation
- Diagnosed with other malignant tumors at the same time
- History of malignant tumors
- Pregnancy, breastfeeding, or plans to become pregnant during the trial
- Presence of serious combined illnesses
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
S
Shuang Wu, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here